PICTON MAHONEY ASSET MANAGEMENT
Position in CRL — Charles River Laboratories International, Inc.
CIK 1539041
Toronto, A6
Position in CRL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$16,455,810
+$1,800,414 QoQ
Shares Held
95,396
+29.8% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
19 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PICTON MAHONEY ASSET MANAGEMENT holds $102,222,185 across 14 Diagnostics & Research names. CRL ranks #5 (16.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
249,991 | $23,091,668 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
44,543 | $21,894,220 | |
| 3 | NTRA |
Natera, Inc.
|
90,161 | $18,031,298 | |
| 4 | RDNT |
RadNet, Inc.
|
309,120 | $17,276,716 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
This page
|
95,396 | $16,455,810 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
5,092 | $2,445,127 | |
| 7 | DGX |
Quest Diagnostics Inc
|
8,030 | $1,573,719 | |
| 8 | A |
Agilent Technologies, Inc.
|
9,297 | $1,059,672 |
All Filings in CRL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,455,810 | 95,396 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $14,655,396 | 73,468 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $12,252,226 | 78,309 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,236,050 | 34,509 | Shares | Sole | 2025-08-12 | |
| 2023-12-31 | $213,942 | 905 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $132,286 | 675 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $422,602 | 2,010 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $462,167 | 2,290 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $358,009 | 1,643 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $187,944 | 955 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,291,928 | 15,385 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $9,105,498 | 32,065 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $13,402,064 | 35,570 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $14,617,596 | 35,422 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $13,399,242 | 36,222 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $8,257,256 | 28,490 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $7,387,110 | 29,565 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,131,133 | 27,075 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,464,540 | 8,400 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||